Ross is a partner in the Corporate Technology & Life Sciences team, based in our Cambridge office.

Ross is a lead partner within the firm's Tier 1-ranked Biotechnology practice in Cambridge. His practice involves helping life sciences and technology companies as they progress through their life cycle in all aspects of their growth, capital raising and international expansion. As a sector specialist, Ross focuses on biotech, medical devices and diagnostics within Life Sciences, and with the Tech sector supports companies operating in the capital intensive deep tech space, including quantum computing, artificial intelligence, advanced materials, as well as web3.

Ross has extensive experience of a variety of venture and growth financing, public capital raisings, mergers and acquisitions and general corporate advice. Ross was based out of San Francisco, CA in 2018 – 19 and as a result, he has a particular expertise in transactions with a transatlantic component. He is an English qualified solicitor and registered foreign legal consultant in California.

Afficher le CV complet Masquer le CV complet

The impact of affluence on the next economy

An international study examining the behaviours, motivations and goals of today’s UHNW individuals. 

Read full report

Actualités et publications récentes

Fusions et acquisitions d’entreprises et marchés financiers internationaux

The AIM market: guides for US issuers

27 avril 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising New Science Ventures as lead investor on Paragraf's $60 million Series B funding round

4 mars 2022

par Ross McNaughton et Adrian Toutoungi

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Placid0 on its acquisition by eyecare brand WALDO

25 février 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Advising Nuclera on its Series B funding round

2 février 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus